By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celyad (Formally Known as Cardio3 BioSciences) 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35


SEARCH JOBS


Industry
Biotechnology






Company News
Celyad Announces First Quarter 2015 Business Update 5/19/2015 10:50:58 AM
Celyad Says It Might Go Shopping With $115 Million IPO As CAR-T Roars 5/18/2015 1:20:19 PM
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015 10:27:15 AM
Cardio3 BioSciences Becomes Celyad 4/15/2015 1:03:38 PM
Cardio3 BioSciences Enrolls First Patient in Phase I Trial For NKG2D CAR T-Cell 4/13/2015 10:48:23 AM
Edison Publishes Research Note On Cardio3 BioSciences, US IPO Intended 4/13/2015 7:04:27 AM
BioLife Solutions, Inc. (BLFS.OB) CryoStor Cell Preservation Media Embedded In Cardio3 BioSciences' Phase III Clinical Trials Of C-Cure Cell Therapy For Congestive Heart Failure 4/9/2015 6:18:58 AM
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015 5:57:32 AM
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015 10:35:53 AM
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015 10:46:41 AM
1234567
//-->